Related references
Note: Only part of the references are listed.Anti-cancer therapies targeting the tumor stroma
Valeska Hofmeister et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Breast-cancer stromal cells with TP53 mutations and nodal metastases
Attila Patocs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
Identification of alterations in DNA copy number in host stromal cells during tumor progression
Robert J. Pelham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice
Lyudmila G. Burdelya et al.
CANCER RESEARCH (2006)
Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation
Frank Weber et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells
T Udagawa et al.
FASEB JOURNAL (2006)
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis
R Hill et al.
CELL (2005)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis
H Kiaris et al.
CANCER RESEARCH (2005)
Induction of centrosome amplification and chromosome instability in p53-null cells by transient exposure to subtoxic levels of S-phase-targeting anticancer drugs
RA Bennett et al.
ONCOGENE (2004)
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas
B Streubel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Tumor-associated endothelial cells with cytogenetic abnormalities
K Hida et al.
CANCER RESEARCH (2004)
Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets
K Fukino et al.
CANCER RESEARCH (2004)
Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas
K Kurose et al.
NATURE GENETICS (2002)
Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability
XD Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The microenvironment of the tumour-host interface
LA Liotta et al.
NATURE (2001)
Post-translational modifications and activation of p53 by genotoxic stresses
E Appella et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Stromal cells can contribute oncogenic signals
TD Tlsty
SEMINARS IN CANCER BIOLOGY (2001)
Share Paper
